Delivery Order SPE2DB22D2009-SPE2DB24FM0CS

Award Date 6/7/24
Potential Completion Date 6/10/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,490,175 units of Rifampin 300 mg capsules, for a ceiling value of $5,601.44. The contract was awarded by the Defense Logistics Agency (DLA) on May 3, 2024, with an ultimate completion date of May 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,133,489 units of rifampin 300 mg capsules. The contract, valued at $1,098.31, has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. The contract is a delivery order with a firm fixed-price pricing type, issued by the Defense agency Medical Supply Chain. Amerisourcebergen, a major pharmaceutical distribution company, does not have a set-aside designation...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,565,453,612 units of the drug Rifampin 300 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $13,361.76 and has an ultimate completion date of August 15, 2024. The contract is not designated as a Set-Aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,379.82 to AmerisourceBergen Drug Corp for the delivery of 4,567,155 units of Rifampin 300 mg capsules. The contract has a period of performance through February 5, 2025 and does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a prime vendor for federal government agencies, particularly the DLA....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,563,216 Rifampin 300 mg capsules. The contract has a ceiling value of $59,634.48 and a period of performance ending on January 3, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this award, which is part of...
This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order valued at $5,850.40 and runs through September 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $1,432.55. The contract is a firm fixed-price Delivery Order with a completion date of July 11, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of 4,567,279,694 units of RIFAMPIN 300 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract, valued at $4,791.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,475.28, is for the delivery of 4566718735 - Rifampin 300 mg Capsule 60s. This is a firm fixed-price delivery order contract with an ultimate completion date of December 16, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,758.10 firm fixed-price delivery order is for the supply of Rifampin 300 mg capsules, a medication used to treat various bacterial infections. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which covers a...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM0CS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $27,852.48 for the delivery of 4,564,840,981 units of Rifampin 300 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of June 10, 2024, awarded by the Defense Logistics Agency (DLA), a defense agency.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This specific award does not utilize any set-aside designations.

Generated 9/6/24, 10:05 AM